No. |
Chromosome Location |
Chromatin state |
Cell line |
Tissue |
1 |
chr17:19457000-19483000 |
Weak transcription |
Psoas Muscle |
Psoas
|
2 |
chr17:19464000-19483800 |
Weak transcription |
A549 |
lung
|
3 |
chr17:19471200-19482800 |
Weak transcription |
Skeletal Muscle Male |
skeletal muscle
|
4 |
chr17:19476600-19482800 |
Weak transcription |
ES-WA7 Cell Line |
embryonic stem cell
|
5 |
chr17:19481000-19483400 |
Enhancers |
Liver |
Liver
|
6 |
chr17:19481200-19485600 |
Weak transcription |
HepG2 |
liver
|
7 |
chr17:19481800-19482800 |
Enhancers |
Cortex derived primary cultured neurospheres |
brain
|
8 |
chr17:19482000-19482800 |
Enhancers |
Colon Smooth Muscle |
Colon
|
9 |
chr17:19482200-19483400 |
Bivalent Enhancer |
Fetal Stomach |
stomach
|
10 |
chr17:19482400-19482800 |
Bivalent Enhancer |
Foreskin Keratinocyte Primary Cells skin03 |
Skin
|
11 |
chr17:19482400-19482800 |
Enhancers |
Brain Anterior Caudate |
brain
|
12 |
chr17:19482400-19482800 |
Bivalent Enhancer |
Duodenum Smooth Muscle |
Duodenum
|
13 |
chr17:19482600-19482800 |
Active TSS |
HUES6 Cell Line |
embryonic stem cell
|
14 |
chr17:19482600-19482800 |
Enhancers |
iPS DF 6.9 Cell Line |
embryonic stem cell
|
15 |
chr17:19482600-19482800 |
Enhancers |
ES-UCSF4 Cell Line |
embryonic stem cell
|
16 |
chr17:19482600-19482800 |
Enhancers |
Gastric |
stomach
|
17 |
chr17:19482600-19482800 |
Bivalent Enhancer |
NHEK |
skin
|
18 |
chr17:19482600-19483000 |
Flanking Bivalent TSS/Enh |
H1 Cell Line |
embryonic stem cell
|
19 |
chr17:19482600-19483000 |
Flanking Active TSS |
iPS DF 19.11 Cell Line |
embryonic stem cell
|
20 |
chr17:19482600-19483000 |
Flanking Active TSS |
Breast Myoepithelial Primary Cells |
Breast
|
21 |
chr17:19482600-19483000 |
Flanking Active TSS |
Primary neutrophils fromperipheralblood |
blood
|
22 |
chr17:19482600-19483000 |
Bivalent Enhancer |
Foreskin Fibroblast Primary Cells skin01 |
Skin
|
23 |
chr17:19482600-19483000 |
Bivalent Enhancer |
Foreskin Fibroblast Primary Cells skin02 |
Skin
|
24 |
chr17:19482600-19483000 |
Bivalent Enhancer |
Foreskin Keratinocyte Primary Cells skin02 |
Skin
|
25 |
chr17:19482600-19483000 |
Bivalent Enhancer |
Fetal Muscle Trunk |
muscle
|
26 |
chr17:19482600-19483200 |
Bivalent Enhancer |
H1 Derived Mesenchymal Stem Cells |
ES cell derived
|
27 |
chr17:19482600-19483200 |
Bivalent Enhancer |
Primary monocytes fromperipheralblood |
blood
|
28 |
chr17:19482600-19483200 |
Flanking Bivalent TSS/Enh |
Fetal Adrenal Gland |
Adrenal Gland
|
29 |
chr17:19482600-19483200 |
Bivalent Enhancer |
Fetal Brain Male |
brain
|
30 |
chr17:19482600-19483400 |
Bivalent/Poised TSS |
Colonic Mucosa |
Colon
|
31 |
chr17:19482600-19483400 |
Enhancers |
Lung |
lung
|
32 |
chr17:19482600-19483800 |
Bivalent/Poised TSS |
HUES48 Cell Line |
embryonic stem cell
|
33 |
chr17:19482600-19483800 |
Bivalent/Poised TSS |
HUES64 Cell Line |
embryonic stem cell
|
34 |
chr17:19482600-19484000 |
Bivalent/Poised TSS |
iPS-15b Cell Line |
embryonic stem cell
|
35 |
chr17:19482600-19484000 |
Bivalent/Poised TSS |
iPS-20b Cell Line |
embryonic stem cell
|
36 |
chr17:19482600-19484000 |
Bivalent Enhancer |
Placenta |
Placenta
|